Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
2 Vues
• 07/17/23
0
0
Intégrer
administrator
Les abonnés
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires